261 related articles for article (PubMed ID: 24210930)
1. Inflammation is more distinct in temporomandibular joint osteoarthritis compared to the knee joint.
Vos LM; Kuijer R; Huddleston Slater JJ; Bulstra SK; Stegenga B
J Oral Maxillofac Surg; 2014 Jan; 72(1):35-40. PubMed ID: 24210930
[TBL] [Abstract][Full Text] [Related]
2. Alteration of cartilage degeneration and inflammation markers in temporomandibular joint osteoarthritis occurs proportionally.
Vos LM; Kuijer R; Huddleston Slater JJ; Stegenga B
J Oral Maxillofac Surg; 2013 Oct; 71(10):1659-64. PubMed ID: 23932112
[TBL] [Abstract][Full Text] [Related]
3. Uncoupling of type II collagen synthesis and degradation predicts progression of joint damage in patients with knee osteoarthritis.
Garnero P; Ayral X; Rousseau JC; Christgau S; Sandell LJ; Dougados M; Delmas PD
Arthritis Rheum; 2002 Oct; 46(10):2613-24. PubMed ID: 12384919
[TBL] [Abstract][Full Text] [Related]
4. Attenuated synovial fluid ghrelin levels are linked with cartilage damage, meniscus injury, and clinical symptoms in patients with knee anterior cruciate ligament deficiency.
Zou YC; Chen LH; Ye YL; Yang GG; Mao Z; Liu DD; Chen JQ; Chen JJ; Liu G
Discov Med; 2016 Dec; 22(123):325-335. PubMed ID: 28147215
[TBL] [Abstract][Full Text] [Related]
5. Intra-articular levels of prostaglandin E2, hyaluronic acid, and chondroitin-4 and -6 sulfates in the temporomandibular joint synovial fluid of patients with internal derangement.
Murakami KI; Shibata T; Kubota E; Maeda H
J Oral Maxillofac Surg; 1998 Feb; 56(2):199-203. PubMed ID: 9461145
[TBL] [Abstract][Full Text] [Related]
6. Cross sectional evaluation of biochemical markers of bone, cartilage, and synovial tissue metabolism in patients with knee osteoarthritis: relations with disease activity and joint damage.
Garnero P; Piperno M; Gineyts E; Christgau S; Delmas PD; Vignon E
Ann Rheum Dis; 2001 Jun; 60(6):619-26. PubMed ID: 11350852
[TBL] [Abstract][Full Text] [Related]
7. Analysis of inflammatory mediators in temporomandibular joint synovial fluid lavage samples of symptomatic patients and asymptomatic controls.
Chang H; Israel H
J Oral Maxillofac Surg; 2005 Jun; 63(6):761-5. PubMed ID: 15944971
[TBL] [Abstract][Full Text] [Related]
8. Urinary type II collagen helical peptide (HELIX-II) as a new biochemical marker of cartilage degradation in patients with osteoarthritis and rheumatoid arthritis.
Charni N; Juillet F; Garnero P
Arthritis Rheum; 2005 Apr; 52(4):1081-90. PubMed ID: 15818703
[TBL] [Abstract][Full Text] [Related]
9. Analysis of the collagen I and fibronectin of temporomandibular joint synovial fluid and discs.
Natiella JR; Burch L; Fries KM; Upton LG; Edsberg LE
J Oral Maxillofac Surg; 2009 Jan; 67(1):105-13. PubMed ID: 19070755
[TBL] [Abstract][Full Text] [Related]
10. Changes in content and synthesis of collagen types and proteoglycans in osteoarthritis of the knee joint and comparison of quantitative analysis with Photoshop-based image analysis.
Lahm A; Mrosek E; Spank H; Erggelet C; Kasch R; Esser J; Merk H
Arch Orthop Trauma Surg; 2010 Apr; 130(4):557-64. PubMed ID: 19838720
[TBL] [Abstract][Full Text] [Related]
11. The release of crosslinked peptides from type II collagen into human synovial fluid is increased soon after joint injury and in osteoarthritis.
Lohmander LS; Atley LM; Pietka TA; Eyre DR
Arthritis Rheum; 2003 Nov; 48(11):3130-9. PubMed ID: 14613275
[TBL] [Abstract][Full Text] [Related]
12. Moderate loading of the human osteoarthritic knee joint leads to lowering of intraarticular cartilage oligomeric matrix protein.
Helmark IC; Petersen MC; Christensen HE; Kjaer M; Langberg H
Rheumatol Int; 2012 Apr; 32(4):1009-14. PubMed ID: 21246372
[TBL] [Abstract][Full Text] [Related]
13. Prostaglandin E2 in temporomandibular joint synovial fluid and its relation to pain and inflammatory disorders.
Alstergren P; Kopp S
J Oral Maxillofac Surg; 2000 Feb; 58(2):180-6; discussion 186-8. PubMed ID: 10670597
[TBL] [Abstract][Full Text] [Related]
14. Glycosaminoglycan components in temporomandibular joint synovial fluid as markers of joint pathology.
Shibata T; Murakami KI; Kubota E; Maeda H
J Oral Maxillofac Surg; 1998 Feb; 56(2):209-13. PubMed ID: 9461147
[TBL] [Abstract][Full Text] [Related]
15. Increased pentosidine, an advanced glycation end product, in serum and synovial fluid from patients with knee osteoarthritis and its relation with cartilage oligomeric matrix protein.
Senolt L; Braun M; Olejárová M; Forejtová S; Gatterová J; Pavelka K
Ann Rheum Dis; 2005 Jun; 64(6):886-90. PubMed ID: 15897309
[TBL] [Abstract][Full Text] [Related]
16. Changes in joint cartilage aggrecan after knee injury and in osteoarthritis.
Lohmander LS; Ionescu M; Jugessur H; Poole AR
Arthritis Rheum; 1999 Mar; 42(3):534-44. PubMed ID: 10088777
[TBL] [Abstract][Full Text] [Related]
17. Cross-sectional association of 10 molecular markers of bone, cartilage, and synovium with disease activity and radiological joint damage in patients with hip osteoarthritis: the ECHODIAH cohort.
Garnero P; Mazières B; Guéguen A; Abbal M; Berdah L; Lequesne M; Nguyen M; Salles JP; Vignon E; Dougados M
J Rheumatol; 2005 Apr; 32(4):697-703. PubMed ID: 15801028
[TBL] [Abstract][Full Text] [Related]
18. Effects of enzymatic degradation after loading in temporomandibular joint.
Asakawa-Tanne Y; Su S; Kunimatsu R; Hirose N; Mitsuyoshi T; Okamoto Y; Tanaka E; Tanne K; Tanimoto K
J Dent Res; 2015 Feb; 94(2):337-43. PubMed ID: 25503611
[TBL] [Abstract][Full Text] [Related]
19. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in synovial fluids of patients with temporomandibular joint osteoarthritis.
Kanyama M; Kuboki T; Kojima S; Fujisawa T; Hattori T; Takigawa M; Yamashita A
J Orofac Pain; 2000; 14(1):20-30. PubMed ID: 11203734
[TBL] [Abstract][Full Text] [Related]
20. Effect of exercise and osteochondral injury on synovial fluid and serum concentrations of carboxy-terminal telopeptide fragments of type II collagen in racehorses.
Cleary OB; Trumble TN; Merritt KA; Brown MP
Am J Vet Res; 2010 Jan; 71(1):33-40. PubMed ID: 20043778
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
